Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Marijuana, drug use a mystery in IBD

Key clinical point: Screening for marijuana use is lacking in inflammatory bowel disease.

Major finding: Fewer than 5% of charts of IBD patients noted marijuana use.

Study details: Chart review of 381 records at a university GI clinic during a 5-year period.

Disclosures: Mr. Baumgartner had no financial relationships to disclose.

Citation:

Baumgartner S et al. Crohn’s & Colitis Congress 2020. 2020 Jan 23. Poster 011.